Apexigen, Inc. - Common Stock APGN 深 沪
等待开盘 04-03 09:30:00 美东时间
0.3851
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 0.3851
- 总市值 957.43万
- 52周最高 8.28
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.3305
- 委 比 0.00%
- 总股本 2486.19万
- 历史最高 31.35
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.3305
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Pyxis Oncology Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Pyxis Oncology, Inc. reported updates on its lead candidate MICVO, including completion of target enrollment in a Phase 1 monotherapy study for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) in the first quarter of 2026. The company also announced updated data expected in mid-2026, which will include patients treated with modified weight-based dosing. Additionally, Pyxis Oncology shared financial results for 2025, includin...
03-23 11:00
89bio names Francis Sarena as COO
89bio (NASDAQ:ETNB) said it has appointed Francis Sarena as COO, effective August 5. Sarena has over two decades of experience, and served as COO and president at Apexigen before joining ETNB. More on...
2024-08-07 20:25
Pyxis Oncology gets $8M payment for sale pf royalty rights
Pyxis Oncology (NASDAQ:PYXS) said it has completed the sale of its rights to royalties from the commercialization of Beovu and another asset to Novartis for a one-time cash payment of $8 million. The ...
2024-03-27 19:43
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVID, CPRI, APGN
NEW YORK, Aug. 11, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...
2023-08-12 02:59
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers HeartBeam (NASDAQ:BEAT) stock rose 20.1% to $2.42 during Thursday's pr...
2023-05-25 21:07
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GNL, RTL, APGN
NEW YORK, May 24, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or ...
2023-05-25 00:37
Pyxis Oncology Bolsters Oncology Portfolio Through $16M Apexigen Acquisition
Pyxis Oncology (NASDAQ:PYXS) has announced an acquisition of Apexigen (NASDAQ:APGN) that is expected to be completed in the second half of 2023.
2023-05-25 00:19
Apexigen shares are trading higher after Pyxis Oncology announced it will acquire the company.
Apexigen shares are trading higher after Pyxis Oncology announced it will acqui...
2023-05-24 20:35
Pyxis Oncology to Acquire Apexigen
Pyxis Oncology positioned at forefront of Antibody-Drug Conjugate (ADC) develop...
2023-05-24 18:45
EF Hutton Maintains Buy on Apexigen, Lowers Price Target to $5
EF Hutton analyst Tony Butler maintains Apexigen (NASDAQ:APGN) with a Buy and lowers the price target from $8 to $5.
2023-05-16 19:12
